A carregar...
Intravenous zoledronate for osteoporosis: less might be more
Annual administration of 5 mg intravenous zoledronate is moderately effective in reducing fracture risk in older adults, decreasing the relative risk of clinical fracture by 33%. However, almost 10 years after its approval for use in clinical practice there remain very substantial uncertainties abou...
Na minha lista:
| Publicado no: | Ther Adv Musculoskelet Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959627/ https://ncbi.nlm.nih.gov/pubmed/27493690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16650866 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|